Christian Hurtz

7PUBLICATIONS
61CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.

|Jun 26, 2026
Multi-Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High-Grade Serous Ovarian Cancer.

|Feb 10, 2026
Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.

Jaewoong Lee, Ruifeng Sun, Kohei Kume

|Jul 17, 2025
Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy.

V S S Abhinav Ayyadevara, Shikha Gaur, Ashley Paik

|Mar 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition.

V S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur

|Dec 08, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams

Pageof 2

Frequent Collaborators

3 joint publications

V S S Abhinav Ayyadevara

2 joint publications

Srividya Swaminathan

2 joint publications

Wayne E Childers

2 joint publications

Monika Toma